Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Donepezil Open Label Extension in MCI
NCT00934375Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Feb 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of donepezil in Mild Cognitive Impairment (MCI), sponsored by Eisai Co., Ltd. Primary endpoint: Number of Participants With Treatment-Emergent Adverse Events at Week 28. Started Feb 2006; status: completed.
02
Drugs
donepezil
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT00934375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00934375.